Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$23,781
+$5,253 QoQ
Shares Held
79
+41.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#654
of 784 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRIVATE TRUST CO NA holds $913,783 across 33 Biotechnology names. ALNY ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,003 | $187,841 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
248 | $154,637 | |
| 4 | INCY |
Incyte Corp
|
593 | $67,222 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
418 | $34,071 | |
| 6 | MRNA |
Moderna, Inc.
|
364 | $25,490 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
79 | $23,781 | |
| 8 | RPRX |
Royalty Pharma plc
|
382 | $21,418 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,781 | 79 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $18,528 | 56 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $11,134 | 28 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $262,200 | 575 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $10,434 | 32 | Shares | Defined | 2025-07-29 | |
| 2024-09-30 | $825 | 3 | Shares | Defined | 2024-11-13 | |
| 2023-03-31 | $200 | 1 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $237 | 1 | Shares | Defined | 2023-01-18 | |
| 2022-09-30 | $200 | 1 | Shares | Defined | 2022-10-17 | |
| 2022-06-30 | $145 | 1 | Shares | Defined | 2022-09-16 | |
| No filing history on record for this holder in this stock. | ||||||